Home/Filings/4/0001213900-21-039435
4//SEC Filing

Greig Russell 4

Accession 0001213900-21-039435

CIK 0001739174other

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 9:50 AM ET

Size

8.1 KB

Accession

0001213900-21-039435

Insider Transaction Report

Form 4
Period: 2021-07-28
Transactions
  • Purchase

    Common Stock

    2021-07-28$4.00/sh+3,750$15,0003,750 total(indirect: See Footnote)
  • Purchase

    Common Stock Warrant

    2021-07-28+2,8132,813 total(indirect: See Footnote)
    Exercise: $5.00From: 2022-01-28Exp: 2027-01-28Common Stock (2,813 underlying)
Footnotes (3)
  • [F1]The common stock and common stock warrant were acquired in the issuer's registered direct offering of units, in which each unit consisted of one share of common stock and one common stock warrant to purchase 0.75 of a share of common stock, at a price of $4.00 per unit. The price paid per unit is reflected in Table I.
  • [F2]The common stock warrant will be exercisable six months after the date of issuance, at an exercise price of $5.00 per share and will expire five years from the date such warrant first becomes exercisable.
  • [F3]The common stock and common stock warrant are held by Greig Biotechnology Global Consulting Inc.; Mr. Greig, as the sole director, an officer and the controlling shareholder of Greig Biotechnology Global Consulting Inc., may be deemed to be a beneficial owner of these shares, but Mr. Greig disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

BiomX Inc.

CIK 0001739174

Entity typeother

Related Parties

1
  • filerCIK 0001789914

Filing Metadata

Form type
4
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 9:50 AM ET
Size
8.1 KB